Cigna Corporation Stock Price and Value Analysis

Should you buy Cigna Corporation stock? (NYSE:CI). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantages
  • This company is very stable.
  • This company has a low dividend yield.
  • This company is making money at a modest rate.
  • This stock looks overpriced.
  • This company has wild ups and downs.

Inside the CI Numbers

CI Price
(Cigna Corporation stock price per share)
$331.45
[?] CI Fair Price
(based on intrinsic value)
$162.51
[?] CI Safety Price (based on a variable margin of safety) $130.01
[?] PE Ratio versus Sector 28% lower than other Healthcare stocks
[?] PE Ratio versus Industry 19% higher than other Unknown stocks
[?] Cash Yield 2.01%
[?] Free Cash Flow Jitter 118%
[?] Dividend Yield 1%
Shares Shorted 4,060,091

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 4,060,091 shares shorted. With 303,795,049 shares available for purchase and an average trading volume over the past 10 trading days of 1,536,320, it would take at least 2.643 days for all of the short holders to cover their shorts.

Is Cigna Corporation Stock on Sale?

We believe that Cigna Corporation may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Cigna Corporation looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy CI Stock?

Does Cigna Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Most Popular Articles